VBI Vaccines, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human use (CHMP) has adopted a positive opinion for VBI’s 3-antigen hepatitis B vaccine, under the brand name PreHevbri™.
[VBI Vaccines, Inc.]
Sorry, but the selected Zotpress account can't be found.
